CIK 0001870404 · <br>Emerging growth company
CERO THERAPEUTICS HOLDINGS, INC.
Sign in to watch- Tickers
- CERO CEROW
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 871088814
- Phone
- 650-407-2376
- Business address
- 201 HASKINS WAY, SUITE 230, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- CERO THERAPEUTICS HOLDINGS, INC., PHOENIX BIOTECH ACQUISITION CORP.
Securities
- CERO Common stock OTC
- CEROW Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-14 | Ehrlich Christopher B Director | Other disposition · Warrants | −349,998 | 0 | ||
| 2024-02-14 | Ehrlich Christopher B Director | Other acquisition · Warrants | +5,000 | 5,000 | ||
| 2024-02-14 | ATWOOD BRIAN G Chief Executive Officer | Other acquisition | +125,000 | 125,000 | ||
| 2024-02-14 | ATWOOD BRIAN G Chief Executive Officer | Other acquisition | +100,527 | 100,527 | ||
| 2024-02-14 | ATWOOD BRIAN G Chief Executive Officer | Other acquisition | +148,208 | 248,735 | ||
| 2024-02-14 | ATWOOD BRIAN G Chief Executive Officer | Grant or award · Series A Convertible Preferred Stock | +1,002 | $1,000.00 | $1.0M | 1,002 |
| 2021-10-08 | PHOENIX BIOTECH SPONSOR, LLC 10% owner | Other acquisition | +36,733 | $10.00 | $367K | 699,996 |
| 2021-10-08 | PHOENIX BIOTECH SPONSOR, LLC 10% owner | Other disposition · Class B Common Stock | −82,875 | 4,596,250 | ||
| 2021-10-08 | PHOENIX BIOTECH SPONSOR, LLC 10% owner | Other acquisition · Warrants | +18,366 | 349,998 | ||
| 2021-10-08 | Ehrlich Christopher B CEO and Secretary | Other acquisition | +36,733 | $10.00 | $367K | 699,996 |
| 2021-10-08 | Ehrlich Christopher B CEO and Secretary | Other disposition · Class B Common Stock | −82,875 | 4,596,250 | ||
| 2021-10-08 | Ehrlich Christopher B CEO and Secretary | Other acquisition · Warrants | +18,366 | 349,998 | ||
| 2021-10-08 | Geffken Daniel E. Chief Financial Officer | Other acquisition · Class B Common Stock | +30,000 | 30,000 | ||
| 2021-10-08 | Loewy Caroline M Director | Other acquisition · Class B Common Stock | +17,500 | 17,500 | ||
| 2021-10-08 | Fisher Douglas President | Other acquisition | +10,000 | 10,000 | ||
| 2021-10-08 | Fisher Douglas President | Other acquisition · Class B Common Stock | +100,000 | 100,000 | ||
| 2021-10-08 | Fisher Douglas President | Other acquisition · Warrants | +5,000 | 5,000 | ||
| 2021-10-08 | LAPORTE KATHLEEN Director | Other acquisition · Class B Common Stock | +17,500 | 17,500 | ||
| 2021-10-08 | ATWOOD BRIAN G Director | Other acquisition · Class B Common Stock | +25,000 | 25,000 | ||
| 2021-10-08 | Kosacz Barbara Director | Other acquisition · Class B Common Stock | +17,500 | 17,500 |
Page 6 of 6 · 120 trades